Metformin has been reported to inhibit the growth of various types of cancers, including prostate cancer. Yet the mode of...
The safety of triple oral therapy with dapagliflozin plus saxagliptin plus metformin versus dual therapy with dapagliflozin or saxagliptin plus metformin was compared in a post-hoc analysis of 3 randomized trials of sequential or concomitant...
Aim: To evaluate the efficacy and safety of triple therapy with low-dose dapagliflozin plus saxagliptin added to metformin in uncontrolled type 2 diabetes.
Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Metformin prolonged-release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin. For study results with respect to effects on glycaemic control and diabetic complications, (see section 5.1).